glp 1 shortage ending As GLP-1 Drug Ends, Why Will Patients Pay More? FDA says that the GLP-1

Protein-first eating reduces the stomach load causing sulfur burps

For example, internal models predicted rapid penetration of Wegovy beyond a few million users, but actual claims suggest a flatter growth curve as of early 2026

Reviews focusing on semaglutide specifically [65] and broader examinations of GLP-1 RA mechanisms and clinical data have consistently concluded that these agents represent important therapeutic advances

GLP-1 receptor agonistsmedications such as semaglutide and liraglutidehave gained attention for their weight management properties, though they were originally developed for type 2 diabetes